On January 24, 2017, the Journal of the American Medical Association (JAMA), published “Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014” by Modak et al. The study found that cancer deaths in the U.S. declined by 20 percent from 1980-2014, but there were large differences in cancer mortality as well as areas with unusually higher mortality rates across counties. The following is a statement from Daniel F. Hayes, MD, FACP, FASCO, President of the American Society of Clinical Oncology (ASCO).
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
ASCO is hosting a congressional briefing to announce Clinical Cancer Advances 2017: ASCO’s Annual Report on Progress Against Cancer and outline how Congress can shape the future of cancer care.
A new set of articles in the Journal of Oncology Practice seek to gain physicians and patients’ perspectives regarding the ethical implementation of a rapid learning system (RLS) in oncology care.
ASCO has submitted comments to the National Institutes of Health (NIH) in response to a Request for Information (RFI) on data sharing and management (NOT-OD-17-015).
As the new Administration gets underway and Congress considers proposals to repeal and replace the Affordable Care Act, ASCO is closely monitoring developments and will continue to strongly urge policymakers to provide access to affordable and sufficient healthcare coverage for all Americans, as stated in the society’s principles for patient-centered healthcare reform.
ASCO is hosting two upcoming events for oncology practices discuss quality and business challenges, including MACRA, alternative payment models, EHRs, and physician burnout.
On January 18, 2017, the Department of Health and Human Services (HHS), along with more than a dozen other federal agencies, finalized updates to the Common Rule, which protects human subjects in biomedical research. This is the first time the Common Rule has been updated in nearly three decades, and the changes make major strides in modernizing protections for human subjects.
We commend the Food and Drug Administration (FDA) for establishing the Oncology Center of Excellence (OCE) with Dr. Richard Pazdur as its director. The FDA has provided not only regulatory guidance but also intellectual leadership in the development of oncology products and this new OCE will build on that past, creating a larger community of scientists and clinician experts within the agency. ASCO looks forward to working with the OCE and the new administration to help improve the lives of people living with cancer.
On January 17, the Food and Drug Administration (FDA) outlined the criteria companies must meet to get a biologic deemed interchangeable with its branded counterpart in draft guidance. Interchangeable biosimilars are expected to offer greater savings to the health system than biosimilars that lack this designation.
On January 16, Diagnosis: Cancer, featured a new blog post by ASCO Chief Medical Officer Richard L. Schilsky, MD, FASCO, FACP, “When Medical Records Can’t Be Shared, We All Lose,” looking at the persisting barriers that prevent the effective sharing of electronic patient records, also known as interoperability, across the healthcare system.
On January 11, representatives from ASCO participated in the final event in the Cancer Moonshot℠ “Making Health Care Better” series, which focused on community oncology, at the White House.
The World Health Organization and the National Cancer Institute released a report on January 10, that finds smoking and its side effects cost the world's economies more than $1 trillion and kill about 6 million people each year. The report also noted that this number is expected to rise by more than a third by 2030. ASCO issued the following statement from President Daniel F. Hayes, MD, FASCO, FACP.
ASCO has released, “ASCO Principles for Patient-Centered Healthcare Reform,” seven recommendations designed to ensure access to high-quality cancer care amid the changing U.S. healthcare delivery landscape. The principles aim to assist the new Congress and Administration, so, as they consider the critical underpinnings of any healthcare reform proposal, the needs of patients facing a cancer diagnosis are met.
As the leading medical professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient care, ASCO is dedicated to working with policymakers and the entire cancer community to provide equal access to quality health care with special emphasis on reducing insurance and economic barriers to cancer care.